Key result
Mitral valve repair and replacement for active mitral endocarditis resulted in similar rates of operative mortality and composite morbidity.
Why the study?
Does mitral valve repair improve outcomes compared to mitral valve replacement in patients with active mitral endocarditis?
Cohort (n=60)
Does mitral valve repair improve outcomes compared to mitral valve replacement in patients with active mitral endocarditis?
Mitral valve repair and replacement for active mitral endocarditis showed similar rates of operative mortality and morbidity, though replacement candidates had higher baseline risk.
Answers are grounded in this paper and cite their sources.
Similar short-term outcomes support individualized repair in selected active mitral endocarditis cases; leaves open randomized confirmation of long-term benefit.
BACKGROUND: A few studies have compared mitral valve repair and replacement in the setting of infective endocarditis, with varying results. We compared the characteristics and outcomes of mitral repair and replacement in endocarditis patients. METHODS: All patients undergoing mitral valve repair or replacement for active mitral endocarditis during 2005-2011 were included. Operative and follow-up mortality, composite morbidity, recurrent endocarditis, and redo operations were prespecified endpoints for analyses. RESULTS: There were 25 and 35 patients undergoing mitral valve repair and replacement, respectively. They were followed-up for 3.9 ± 2.5 years. Valve replacement patients were older (p = 0.029), had a higher prevalence of intracardiac abscess (p = 0.035), previous endocarditis (p = 0.036), atrial fibrillation (p = 0.001), worse renal function (p = 0.013), higher risk scores (p = 0.004-0.020), and longer operation times (p < 0.001). Repair and replacement had similar rates of operative mortality (4.0% vs. 8.6%, p = 0.634), composite morbidity (16.0% vs. 28.6%, p = 0.357), survival (p = 0.564), recurrent endocarditis (p = 0.081), and redo operations (p = 0.813). Independent predictors of operative mortality were preoperative inotropic or intraaortic balloon pump support. The independent predictor of mortality during follow-up was dialysis. Independent predictors of composite morbidity were intracardiac abscess and hypercholesterolemia. The independent predictor of recurrent endocarditis was previous endocarditis, and the independent predictor of redo operation was previous stroke. CONCLUSION: Mitral valve replacement candidates had more baseline risk factors and higher raw rates of postoperative mortality and morbidity, which did not reach statistical significance.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2014) conducted a cohort in active mitral endocarditis (n=60). Mitral valve repair vs. Mitral valve replacement was evaluated on Operative mortality (p=0.634). Mitral valve repair and replacement for active mitral endocarditis resulted in similar rates of operative mortality and composite morbidity.
Synapse has enriched 10 related papers. Consider them for comparative context: